Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association between the CHEK2*1100delC germ line mutation and estrogen receptor status.
de Bock GH, Mourits MJ, Schutte M, Krol-Warmerdam EM, Seynaeve C, Blom J, Brekelmans CT, Meijers-Heijboer H, van Asperen CJ, Cornelisse CJ, Devilee P, Tollenaar RA, Klijn JG. de Bock GH, et al. Among authors: krol warmerdam em. Int J Gynecol Cancer. 2006;16 Suppl 2:552-5. doi: 10.1111/j.1525-1438.2006.00694.x. Int J Gynecol Cancer. 2006. PMID: 17010071
Dutch breast reconstruction guideline.
Mureau MAM; Breast Reconstruction Guideline Working Group. Mureau MAM, et al. J Plast Reconstr Aesthet Surg. 2018 Mar;71(3):290-304. doi: 10.1016/j.bjps.2017.12.020. Epub 2017 Dec 27. J Plast Reconstr Aesthet Surg. 2018. PMID: 29325808 Review.
CHEK2*1100delC homozygosity in the Netherlands--prevalence and risk of breast and lung cancer.
Huijts PE, Hollestelle A, Balliu B, Houwing-Duistermaat JJ, Meijers CM, Blom JC, Ozturk B, Krol-Warmerdam EM, Wijnen J, Berns EM, Martens JW, Seynaeve C, Kiemeney LA, van der Heijden HF, Tollenaar RA, Devilee P, van Asperen CJ. Huijts PE, et al. Among authors: krol warmerdam em. Eur J Hum Genet. 2014 Jan;22(1):46-51. doi: 10.1038/ejhg.2013.85. Epub 2013 May 8. Eur J Hum Genet. 2014. PMID: 23652375 Free PMC article.
Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases.
Huijts PE, Vreeswijk MP, Kroeze-Jansema KH, Jacobi CE, Seynaeve C, Krol-Warmerdam EM, Wijers-Koster PM, Blom JC, Pooley KA, Klijn JG, Tollenaar RA, Devilee P, van Asperen CJ. Huijts PE, et al. Among authors: krol warmerdam em. Breast Cancer Res. 2007;9(6):R78. doi: 10.1186/bcr1793. Breast Cancer Res. 2007. PMID: 17997823 Free PMC article.